146 results
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
2 Aug 24
Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
4:30pm
, in thousands, except per share data)
Three Months Ended
Six Months Ended
June 30,
Revenue, net
Cost of revenue
Gross Profit
Sales and marketing
Research … and development
General and administrative
Acquisition amortization expense
Total operating expenses
Operating income
Interest accretion expense
Note
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
9 May 24
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
4:29pm
, except per share data)
Three Months Ended
March 31,
Revenue, net
Cost of revenue
Gross Profit
Sales and marketing
Research and development
General
8-K
EX-99.1
x356spr8k17gf
12 Mar 24
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
7:42pm
8-K
EX-99.1
b64wde bz
8 Nov 23
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
5:14pm
8-K
EX-99.1
2mgj2pfl
9 Aug 23
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
3:47pm
8-K
EX-10.1
tlay681rhcouplw51
1 Aug 23
Departure of Directors or Certain Officers
8:59pm
8-K
EX-99.1
8h7qcj
12 May 23
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
4:34pm
8-K
EX-99.1
6yywdbq3vh7l
14 Nov 22
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results
4:52pm